医学
心力衰竭
射血分数
扩张型心肌病
内科学
心脏病学
置信区间
不利影响
荟萃分析
舒张期
辅助治疗
相对风险
心肌病
血压
作者
Hongyuan Bai,Yafeng Li,Ke Han,Min Gong,Aiqun Ma
标识
DOI:10.1089/acm.2012.0361
摘要
This meta-analysis indicated that biomedical treatment plus CHM is more effective than biomedical treatment alone in treating patients with DCM and heart failure. However, further studies with long-term follow-up, systemic adverse events evaluation, and other ethnic groups are still required to verify the efficacy and safety of CHM as an adjunctive treatment in all patients with DCM and heart failure.
科研通智能强力驱动
Strongly Powered by AbleSci AI